Get the Stockscreener App
2.36
2.61%
0.06
After Hours:
2.43
0.07
+2.97%
Theratechnologies Inc stock is traded at $2.36, with a volume of 60,889.
It is up +2.61% in the last 24 hours and down -8.88% over the past month.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
See More
Previous Close:
$2.30
Open:
$2.28
24h Volume:
60,889
Relative Volume:
0.02
Market Cap:
$117.25M
Revenue:
$84.32M
Net Income/Loss:
$-3.16M
P/E Ratio:
-47.20
EPS:
-0.05
Net Cash Flow:
$-4.50M
1W Performance:
-3.28%
1M Performance:
-8.88%
6M Performance:
+28.26%
1Y Performance:
+69.18%
1-Day Range:
$2.28
$2.395
1-Week Range:
$2.24
$2.44
52-Week Range:
$1.12
$3.13
Theratechnologies Inc Stock (THTX) Company Profile
Compare THTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
THTX
Theratechnologies Inc
|
2.36 | 117.25M | 84.32M | -3.16M | -4.50M | -0.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.03 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.74 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
329.77 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
545.11 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.32 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Theratechnologies Inc Stock (THTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-17-22 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-29-21 | Downgrade | Canaccord Genuity | Buy → Hold |
Theratechnologies Inc Stock (THTX) Latest News
How the (TH) price action is used to our Advantage (TH:CA) - news.stocktradersdaily.com
(TH) Comprehensive Trading Strategy Report (TH:CA) - news.stocktradersdaily.com
Theratechnologies completes a US$25 million cross-border public offering and concurrent private placement with an innovative capital structure component - Fasken
WorkJam announces US$35 million growth financing from Silver Lake Waterman - Fasken
(TH) Trading Signals (TH:CA) - news.stocktradersdaily.com
(TH) Trading Strategy and Analysis (TH:CA) - news.stocktradersdaily.com
BNP Paribas Financial Markets Acquires New Shares in Theratechnologies Inc. (NASDAQ:THTX) - Defense World
Learn to Evaluate (TH) using the Charts (TH:CA) - news.stocktradersdaily.com
(TH) Long Term Investment Analysis (TH:CA) - news.stocktradersdaily.com
Theratechnologies Reports on its Annual Meeting of Shareholders - The Manila Times
Theratechnologies Reports on its Annual Meeting of Shareholders | THTX Stock News - GuruFocus
Theratechnologies Shareholders Show Strong Support: 84% Approval for Board Nominees at Annual Meeting - Stock Titan
Theratechnologies secures US$15M second ranking secured subordinated term loan from Investissement Québec - McCarthy Tétrault
Theratechnologies Inc. closes public offering of common shares and concurrent private placement with Investissement Quebec for a total amount of US25$M - McCarthy Tétrault
(TH) Technical Patterns and Signals (TH:CA) - news.stocktradersdaily.com
(TH) Stock Evaluation Report (TH:CA) - news.stocktradersdaily.com
(TH) Investment Report (TH:CA) - news.stocktradersdaily.com
Raymond James Financial Inc. Makes New $27,000 Investment in Theratechnologies Inc. (NASDAQ:THTX) - Defense World
(TH) Investment Analysis and Advice (TH:CA) - news.stocktradersdaily.com
Objective long/short (TH) Report (TH:CA) - news.stocktradersdaily.com
Analyzing Theratechnologies (NASDAQ:THTX) and NexImmune (NASDAQ:NEXI) - Defense World
JPMorgan Chase & Co. Buys New Stake in Theratechnologies Inc. (NASDAQ:THTX) - Defense World
When the Price of (TH) Talks, People Listen (TH:CA) - news.stocktradersdaily.com
Theratechnologies, Inc. to Host Earnings Call - ACCESS Newswire
(TH) Market Performance Analysis (TH:CA) - news.stocktradersdaily.com
Theratechnologies announces annual shareholder meeting By Investing.com - Investing.com Canada
Theratechnologies announces annual shareholder meeting - Investing.com Australia
Theratechnologies to Hold Virtual Annual Shareholder Meeting on May 29, 2025 - TipRanks
Stocks In Play: Theratechnologies Inc. By Baystreet.ca - Investing.com Canada
Theratechnologies Inc. - MENAFN.com
Stocks In Play: Theratechnologies Inc. - Barchart.com
Aegis Brands Inc. - Baystreet.ca
Theratechnologies (THTX) Presents Data on Visceral Fat and Muscle Quality in HIV | THTX Stock News - GuruFocus
Theratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV - The Manila Times
Theratechnologies Presents Novel Data at ACTHIV 2025 - GlobeNewswire
(TH) Stock Market Analysis (TH:CA) - news.stocktradersdaily.com
Press Release Distribution & PR Platform - ACCESS Newswire
(TH) Advanced Trading Insights (TH:CA) - news.stocktradersdaily.com
Theratechnologies Hits New High After Deflecting Acquisition Attempts - Finimize
(TH) Pivots Trading Plans and Risk Controls (TH:CA) - news.stocktradersdaily.com
Is Theratechnologies Inc. (THTX) the Best Rising Penny Stock to Buy According to Analysts? - Insider Monkey
Theratechnologies to further evaluate potential sale of company - MSN
Theratechnologies: A High-Risk, High-Reward Speculation As Shares Trade At 39% Discount To Future Pak's $3.51-$4.50 Offer (NASDAQ:THTX) - Seeking Alpha
What is Leede Financial’s Forecast for THTX FY2025 Earnings? - Defense World
Theratechnologies Evaluates Potential Sale Amid Future Pak Proposal - TipRanks
Theratechnologies (THTX) Explores Sale Amid Ongoing Discussions - GuruFocus
Theratechnologies (THTX) Explores Potential Sale Amidst Future P - GuruFocus
Theratechnologies Provides Update on Sale Process - GlobeNewswire
Major Acquisition Alert: Theratechnologies Opens Sale Process Following Buyout Interest - Stock Titan
Theratechnologies Engages in Exclusive Acquisition Talks - TipRanks
Soleus Capital Urges Theratechnologies (THTX) Acquisition - GuruFocus
Theratechnologies Inc Stock (THTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):